The optimization of glucocorticoid therapy for long term treatment in Connective Tissue Diseases
Similar Tracks
Screening and treatment of systemic sclerosis-associated PAH: where do we stand in 2024?
ERN ReCONNET
Keynote —Education for Collective Intelligence
Connected Intelligence Centre | University of Technology, Sydney
No.1 Toxicologist: These Products Were Making Me Infertile And Are Harming Your Future Kids!
The Diary Of A CEO
Connective Tissue Disease: The Intersection Between Rheumatology and Dermatology
Breakthroughs for Physicians